- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Starpharma Holdings Ltd (SPL)
Track today's live Starpharma Holdings (SPL) share price, performance and key data on this page with our current Sydney:SPL stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Starpharma Holdings share price on the Sydney exchange. Use the dropdown to switch exchange for the SPL share price, head to our technical summary section, which provides analysis on Starpharma Holdings share price buy/sell indicators using real-time data (or discuss the Starpharma Holdings (SPL) stock price today with other investors in the Starpharma Holdings ASX share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ASX:SPL share price (ISIN: AU000000SPL0) to enhance your trading decisions with our free investment tools and resources.
What Is the Starpharma Holdings Ltd Share Price Today?
The Starpharma Holdings share price today is 0.715.
What Is the Stock Symbol for Starpharma Holdings Ltd
The stock symbol (or 'ticker') for Starpharma Holdings Ltd is "SPL."
What Stock Exchange Does Starpharma Holdings Ltd Trade On?
Starpharma Holdings Ltd is listed and trades on the Sydney stock exchange.
Is Starpharma Holdings Ltd a Good Stock to Buy?
Determining whether Starpharma Holdings (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current ASX:SPL share price (ISIN: AU000000SPL0) to enhance your trading decisions with our free investment tools and resources.
What Is the Starpharma Holdings Ltd Share Price Today?
The Starpharma Holdings share price today is 0.715.
What Is the Stock Symbol for Starpharma Holdings Ltd
The stock symbol (or 'ticker') for Starpharma Holdings Ltd is "SPL."
What Stock Exchange Does Starpharma Holdings Ltd Trade On?
Starpharma Holdings Ltd is listed and trades on the Sydney stock exchange.
Is Starpharma Holdings Ltd a Good Stock to Buy?
Determining whether Starpharma Holdings (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
0.715
0.000(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.715
0.725
52 wk Range
0.110
0.815
SPL is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.7150.725
52 wk Range
0.1100.815
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
SPL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
1.250
Upside
+74.83%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 1.250
(+74.83% Upside)
Earnings
Latest Release
25/08/2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
Compare SPL to Peers and Sector
Metrics to compare | SPL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSPLPeersSector | |
|---|---|---|---|---|
P/E Ratio | −45.7x | −7.3x | −0.4x | |
PEG Ratio | −2.77 | −0.12 | 0.00 | |
Price/Book | 24.7x | 1.9x | 2.6x | |
Price / LTM Sales | 26.9x | 6.0x | 3.1x | |
Upside (Analyst Target) | 74.8% | 107.4% | 48.2% | |
Fair Value Upside | Unlock | 14.3% | 6.5% | Unlock |
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications in Australia and internationally. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis (BV) and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom coating. It also involved in the development of a dendrimer-enhanced product (DEP) delivery platform, consisting of DEP SN38 for the treatment of ovarian and colorectal cancer that is in Phase II clinical trial; DEP cabazitaxel for prostate and ovarian cancer treatment that is in Phase II clinical trial; and DEP docetaxel to treat pancreatic and other cancers that is in Phase II clinical trial. In addition, the company is developing DEP HER2 radiodiagnostic and DEP HER2 ADC to treat solid tumors; DEP technology for antibody-drug conjugates; and SPL7013 for vaginal gel, a treatment of bacterial vaginosis and prevention of recurrent BV, and an antiviral condom. It has a collaboration agreement with Medicxi to develop petalion therapeutics, a novel cancer therapy using Starpharma’s dendrimer technology. Starpharma Holdings Limited was incorporated in 1997 and is based in Abbotsford, Australia.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Starpharma Holdings (Sydney: SPL) Share Price Today?
The Starpharma Holdings stock price today is 0.715 AUD.
What Stock Exchange Does Starpharma Holdings (SPL) Trade On?
Starpharma Holdings is listed and trades on the Sydney Stock Exchange.
What Is the Ticker (Stock Symbol) for Starpharma Holdings?
The stock symbol (also called a 'ticker') for Starpharma Holdings is "SPL."
What Is the Current Starpharma Holdings Market Capitalisation?
As of today, Starpharma Holdings (Sydney: SPL) market cap is 340.950M AUD.
What Is Starpharma Holdings's (SPL) Earnings Per Share (TTM)?
The Starpharma Holdings EPS is currently -0.020 (Trailing Twelve Months).
When Is the Next Starpharma Holdings Earnings Date?
Starpharma Holdings's next earnings report will be released on 10/11/2026.
Is SPL a Buy or Sell From a Technical Analyst Perspective?
Based on today's Starpharma Holdings moving averages and other technical indicators, the daily buy/sell signal for SPL stock is Strong Sell.
How Many Times Has Starpharma Holdings Stock Split?
Starpharma Holdings has split 0 times. (See the SPL stock split history page for full effective split date and price information.)
How Many Employees Does Starpharma Holdings Have?
Starpharma Holdings has 50 employees, based on their latest Companies House report.
What is the current trading status of Starpharma Holdings (Sydney: SPL)?
As of 29/08/2026, Starpharma Holdings (SPL) is trading at a share price of 0.715 AUD, with a previous close of 0.715 AUD. The stock has fluctuated within a day range of 0.715 AUD to 0.725 AUD, while its 52-week range spans from 0.110 AUD to 0.815 AUD.
What Is Starpharma Holdings (SPL) Price Target According to Analysts?
The average 12-month price target for Starpharma Holdings is 1.250 AUD, with a high estimate of 1.25 AUD and a low estimate of 1.25 AUD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +74.83% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.